Perhaps you saw this Tweet or the NY Times article on this "pre-print" lambasting rapid test accuracy.

Many pre-prints that gain media attention have numerous red flags, especially with regard to vague methodology.

I will summarize two red flags.
nytimes.com/2022/01/05/hea…

https://twitter.com/michaelmina_lab/status/1478798030618906632

🚩 The sample size was 30 employees, but they provide no flow diagram on how they narrowed down to 30 from the "hundreds" 🙄 of people surveilled.

Did they only focus on 30 people who had discrepant rapid test results?

Table and file names suggest so.

Did you know, the FDA has a long-standing mechanism by which it could make Covid #vaccines available quickly to interested families of children <5 years old?

It's called "expanded access" or "compassionate use."

Essentially electing to be in an ongoing trial.

THREAD Presently, the Covid vaccines have low risk, but the efficacy may not be strong enough for kids <5 unless they get a 3rd dose.

Trials may not finish until Mar/Apr, perhaps approved in May/Jun, kids not dosed & "boosted" until Dec 2022!

Too slow!

Omicron should remind us that the pandemic is predictably unpredictable.

How do we approach this unpredictable course using knowledge from #PublicHealth, #Business, and #Psychology?

THREAD: Public health: We need layered mitigation. N95 or better masks in public indoor places, 3-dose mRNA vaccines, vaccine mandates, low-cost rapid testing, air quality monitors, indoor air filters.

When one layer weakens or fails, the others carry the weight.

Live: International dream team of air quality experts talking about how we're not doing enough to prevent #delta transmission in schools
Worst-case scenario: Children's hospitals overloaded with 1/3th the beds needed, and 1/5th the PICU beds needed